Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Keidel

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The New England Journal of Medicine|January 5, 2022
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced MelanomaHussein A Tawbi, Dirk Schadendorf, Evan J Lipson, et al.
Nature Reviews. Rheumatology|January 25, 2018
Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Nature Reviews. Rheumatology|December 8, 2017
The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The New England Journal of Medicine|January 5, 2022
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced MelanomaHussein A Tawbi, Dirk Schadendorf, Evan J Lipson, et al.
Nature Reviews. Rheumatology|January 25, 2018
Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Nature Reviews. Rheumatology|December 8, 2017
The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Pageof 2